 Home > Active Ingredient News > Antitumor Therapy > Merck autonomously withdraws Keytruda in the U.S. for indications for metastatic small cell lung cancer

Merck autonomously withdraws Keytruda in the U.S. for indications for metastatic small cell lung cancer

 Last Update: 2021-03-19
 Source: Internet
 Author: User

Tags

alk lung cancer

types solar cell

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 1, Merck announced the voluntary withdrawal of Keytruda (pembrolizumab) in the United States for the treatment of patients with metastatic small cell lung cancer (SCLC) who have undergone platinum-based chemotherapy and at least one other treatment regimen or after the disease has progressed.

FDA

Keytruda has been approved in the United States for the treatment of melanoma, non-small cell lung cancer, small cell lung cancer, head and neck squamous cell carcinoma, urothelial cancer, colorectal cancer ,18 cancer types including stomach cancer , esophageal cancer, cervical cancer and liver cancer.

Colorectal cancerStomach cancer

At present, Keytruda has not been approved for the treatment of SCLC indications in China, and domestic PD-1 has not been approved for this indication.

In addition to Opdivo and Keytruda's research on the treatment of SCLC.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.